Finding top-quality stocks in a volatile market can feel overwhelming, but quantitative screening helps eliminate bias and guesswork. Stock Reports Plus, powered by Refinitiv (LSEG), performs rigorous company-level analysis across 4,000+ listed equities.
To help investors build institutional-grade portfolios, we focus on companies achieving a rare perfect score of 10 out of 10. Combining this quantitative rating with consensus “Strong Buy” and “Buy” recommendations from institutional analysts via the Institutional Brokers’ Estimate System (IBES) reveals actionable stock ideas backed by rock-solid fundamentals.
Anatomy of a Perfect 10/10 Score
Achieving a top rating on Stock Reports Plus is statistically rare—fewer than 4% of listed companies qualify at any given time. To earn a 10/10, a stock must pass an algorithmic evaluation across five core pillars:
-
Earnings Strength: Consistent earnings surprises, positive forward estimates, and upward broker revisions.
-
Fundamental Health: Strong balance sheet metrics, including healthy Return on Equity (ROE), high Return on Capital Employed (ROCE), and manageable debt levels.
-
Relative Valuation: Attractive Price-to-Earnings (P/E) and Price-to-Book (P/B) multiples compared to peer groups and historical averages.
-
Risk Profile: Low downside volatility (Beta) and proven resilience during broader market drawdowns.
-
Price Momentum: Technical outperformance relative to key benchmarks and critical moving averages (e.g., 50-day and 200-day DMA).
Why Combining Scores with IBES Analyst Recommendations Matters
While a quantitative 10/10 indicates strong historical performance and technical alignment, pairing it with institutional broker forecasts provides a forward-looking sanity check:
-
Filter Out Value Traps: A stock might score high on low valuation metrics, but institutional analyst reviews ensure there are no hidden structural risks.
-
Confirm Earnings Trajectory: IBES forecasts provide forward target prices and earnings growth estimates over a 12-month horizon.
-
Institutional Backing: High analyst conviction (“Buy” / “Strong Buy”) points to ongoing support from foreign and domestic institutional funds.
By filtering the market through both quantitative metrics and institutional consensus, investors can build resilient, high-conviction portfolios designed to navigate volatility while capturing long-term upside.
